7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 
      
    		                   
      cash flows from operating activities
    		                   
      net income
    		80,694,000 69,244,000 2,804,000 80,360,000 -100,222,000 -45,136,000 -133,936,000 -166,902,000 -171,783,000 -205,962,000 -205,677,000 -322,437,000 -251,269,000 -186,396,000 -54,671,000 -159,735,000 -306,615,000 -153,208,000 -230,883,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                   
      benefit from losses
    		162,752,000 156,627,000 147,252,000 152,980,000 159,824,000               
      amortization of premiums and discounts on loans
    		-65,072,000 -61,972,000 -60,530,000 -59,233,000 -52,064,000 -50,026,000 -49,704,000 -46,841,000 -41,138,000 -37,607,000 -34,615,000 -34,258,000 -34,595,000 -42,251,000 -42,036,000 -51,970,000 -35,708,000 -29,666,000 -29,252,000 
      gain on sales of loans
    		-119,049,000 -116,883,000 -75,839,000 -125,287,000 -63,613,000 -69,983,000 -40,183,000 -52,702,000 -34,285,000 -32,326,000 -32,813,000 -59,607,000 -63,595,000 -55,282,000 -52,484,000 -57,690,000 -30,979,000  -16,350,000 
      gain on extinguishment of debt
    		-1,495,000 0 0 -62,794,000 -19,624,000 -7,279,000              
      changes in fair value of assets and liabilities
    		-110,000 1,690,000 834,000 2,954,000 1,668,000 869,000 1,267,000 -802,000 -4,110,000 -5,866,000 1,018,000 -14,941,000 3,906,000 -62,968,000 -143,721,000 -34,984,000 139,884,000   
      amortization of commercial agreement assets
    		8,056,000 7,968,000 10,913,000 14,255,000 14,256,000 14,101,000 15,855,000 21,557,000 21,557,000 21,322,000 21,088,000 21,557,000 21,557,000 23,933,000 28,919,000 24,914,000 18,971,000 19,006,000  
      amortization of debt issuance costs
    		6,828,000 7,091,000 10,308,000 6,907,000 6,083,000 5,658,000 6,130,000 7,224,000 5,534,000 7,337,000 11,446,000 676,000 1,076,000 2,937,000 3,647,000 4,337,000 5,231,000 2,741,000 1,314,000 
      accrued interest on securities available for sale
    		-9,959,000                   
      commercial agreement warrant expense
    		40,977,000 41,460,000 36,063,000 86,776,000 107,263,000 100,126,000 95,973,000 114,705,000 95,910,000 91,216,000 93,922,000 128,053,000 108,743,000 97,656,000 92,169,000     
      stock-based compensation
    		85,853,000 65,495,000 75,607,000 86,098,000 94,233,000 64,913,000 77,075,000 90,164,000 112,359,000 103,337,000 106,789,000 121,775,000 119,808,000 110,870,000 98,387,000 88,537,000 93,189,000 135,562,000 139,747,000 
      depreciation and amortization
    		65,329,000 63,995,000 59,467,000 54,894,000 46,720,000 65,389,000 37,012,000 26,512,000 40,131,000 43,279,000 47,469,000 23,004,000 20,882,000 17,115,000 13,102,000 11,964,000 10,541,000 7,887,000 5,021,000 
      other
    		-4,930,000 3,723,000 12,131,000 58,000 -2,209,000 -47,505,000 6,514,000 20,390,000 -4,730,000 -9,119,000 -842,000 -917,000 2,053,000 -67,429,000 -527,000 -9,200,000 4,002,000 2,775,000 113,000 
      change in operating assets and liabilities:
    		                   
      purchases and origination of loans held for sale
    		-749,202,000 -338,211,000 -789,323,000 -1,043,397,000 -1,219,022,000               
      proceeds from the sale of loans held for sale
    		748,761,000 338,187,000 789,362,000 1,043,380,000 1,219,061,000 1,048,639,000 900,864,000 1,034,074,000 1,228,110,000 1,336,197,000 1,409,577,000 1,720,835,000 1,707,838,000 1,713,116,000 1,261,160,000 1,719,179,000 888,580,000 995,281,000 597,881,000 
      accounts receivable
    		138,862,000 -208,849,000 -19,884,000 102,664,000 41,117,000 -61,991,000 10,721,000 -74,279,000 -42,208,000 -65,906,000 61,632,000 -56,767,000 -6,649,000 -20,233,000 5,650,000 -36,041,000 -12,076,000 -16,473,000 2,619,000 
      other assets
    		30,955,000 5,817,000 9,429,000 -20,588,000 -6,833,000 -26,953,000 99,850,000 -29,103,000 -12,566,000 -11,174,000 10,435,000 -10,727,000 -3,000,000 -43,039,000 -37,404,000 -12,664,000 78,086,000 -341,000 -191,892,000 
      accounts payable
    		-24,801,000 41,762,000 -9,568,000 -6,936,000 16,543,000 5,795,000 -24,581,000 32,460,000 -1,257,000 -1,420,000 480,000 -5,560,000 1,462,000 -15,913,000 3,396,000 -380,265,000 368,096,000 28,159,000 -3,798,000 
      payable to third-party loan buyers
    		-17,910,000 34,703,000 19,751,000 5,210,000 -7,608,000               
      accrued interest payable
    		1,621,000 2,769,000 -2,277,000 1,048,000 846,000 1,525,000 650,000 2,699,000 6,264,000 -113,000 2,125,000 6,981,000 -1,078,000 3,667,000 371,000 -684,000 553,000 -1,140,000 736,000 
      accrued expenses and other liabilities
    		-3,586,000 -30,130,000 1,453,000 3,489,000 -23,755,000 -11,203,000 -6,971,000 -16,359,000 -20,636,000 7,123,000 -34,888,000 -13,631,000 3,231,000 38,745,000 19,677,000 20,716,000 -11,848,000 -8,977,000 111,800,000 
      net cash from operating activities
    		374,572,000 74,637,000 210,388,000 312,017,000 196,867,000 68,763,000 208,152,000 74,321,000 98,902,000 43,789,000 -54,275,000 -28,548,000 51,215,000 -59,109,000 -27,981,000 -440,254,000 365,150,000 -19,913,000 -123,258,000 
      capex
    		0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
      free cash flows
    		374,572,000 74,637,000 210,388,000 312,017,000 196,867,000 68,763,000 208,152,000 74,321,000 98,902,000 43,789,000 -54,275,000 -28,548,000 51,215,000 -59,109,000 -27,981,000 -440,254,000 365,150,000 -19,913,000 -123,258,000 
      cash flows from investing activities
    		                   
      purchases and origination of loans held for investment
    		-9,797,362,000 -9,817,626,000 -7,676,063,000 -8,663,556,000 -6,388,350,000 -5,931,339,000 -5,223,719,000 -6,103,822,000 -4,229,667,000 -3,963,962,000 -3,086,832,000 -3,790,632,000 -2,744,825,000 -2,832,724,000 -2,876,978,000 -2,804,888,000 -1,847,458,000   
      proceeds from the sale of loans held for investment
    		4,282,839,000 4,449,448,000 2,858,471,000 3,633,664,000 1,630,671,000 1,878,780,000 1,203,078,000 2,077,703,000 899,238,000 488,607,000 390,907,000 376,274,000 326,713,000 568,266,000 550,065,000 585,237,000 195,039,000   
      principal repayments and other loan servicing activity
    		5,359,253,000 5,005,990,000 4,988,174,000 4,528,811,000 4,132,682,000 3,832,744,000 3,777,977,000 3,351,462,000 3,184,851,000 2,828,884,000 2,570,743,000 2,422,100,000 2,206,725,000 2,254,000,000 2,304,460,000 2,077,024,000 1,486,099,000   
      additions to property, equipment and software
    		-54,365,000 -51,120,000 -53,012,000 -43,905,000 -44,152,000 -38,256,000 -46,476,000 -38,747,000 -35,817,000 -24,858,000 -30,516,000 -34,250,000 -31,151,000 -27,036,000 -21,095,000 -21,812,000 -16,347,000 -7,838,000 -5,351,000 
      purchases of securities available for sale
    		-146,462,000 -270,291,000 -368,710,000 -48,158,000 -136,727,000 -524,829,000 -267,920,000 -96,509,000 -96,813,000 -515,886,000 -460,632,000 -1,000,000 -104,629,000 -1,071,333,000 -258,323,000 -68,164,000 -443,560,000   
      proceeds from maturities and repayments of securities available for sale
    		216,425,000 231,390,000 263,817,000 504,890,000 215,680,000 245,062,000 409,846,000 219,736,000 262,293,000 409,710,000 329,636,000 333,657,000 464,492,000 119,181,000 132,728,000 58,237,000 889,000   
      other investing inflows
    		61,000                   
      other investing outflows
    		                   
      net cash from investing activities
    		-139,611,000 -454,514,000 35,517,000 -89,068,000 -574,999,000 -537,633,000 -146,755,000 -624,902,000 -15,859,000 -777,174,000 -300,958,000 -692,211,000 117,273,000 -1,025,717,000 -166,048,000 -190,063,000 -629,510,000 84,345,000 -199,668,000 
      cash flows from financing activities
    		                   
      proceeds from the issuance of funding debt
    		7,980,435,000 7,150,247,000 6,130,641,000                 
      proceeds from issuance of notes and certificates by securitization trust
    		1,100,000,000 750,000,000 1,000,000,000 0 750,000,000               
      principal repayments of funding debt
    		-7,818,589,000 -7,455,067,000 -6,383,990,000 -4,259,168,000 -3,289,384,000 -3,588,105,000 -2,673,508,000 -3,352,650,000 -2,938,674,000 -1,606,421,000 -2,048,075,000 -1,087,428,000 -1,059,607,000 -1,517,686,000 -1,045,308,000 -653,790,000 -873,778,000 -609,404,000 -1,011,197,000 
      principal repayments of notes issued by securitization trust
    		-1,100,000,000 0                  
      payment of debt issuance costs
    		-9,466,000 -6,474,000 -19,689,000 -18,749,000 -4,321,000 -8,114,000 -2,908,000 -5,790,000 -10,490,000 -5,036,000 -12,634,000 2,650,000 -7,423,000 -5,597,000 -3,000 -1,542,000 -6,609,000 -1,233,000 -4,479,000 
      extinguishment of convertible debt
    		-24,814,000 0 0 -892,800,000 -120,056,000 -38,001,000    116,726,000          
      proceeds from exercise of common stock options and warrants and contributions to espp
    		94,828,000 10,777,000 10,527,000 35,792,000 3,596,000 6,804,000 1,154,000 21,556,000 3,611,000 6,859,000 663,000 7,233,000 1,013,000 6,174,000 8,171,000     
      taxes paid related to net share settlement of equity awards
    		-112,307,000                   
      net cash from financing activities
    		110,086,000 387,259,000 -245,555,000 144,096,000 465,625,000 145,969,000 112,029,000 506,345,000 148,806,000 609,549,000 -128,959,000 669,813,000 199,542,000 -28,881,000 55,787,000 1,766,260,000 243,953,000 -176,129,000 1,488,628,000 
      effect of exchange rate changes on cash, cash equivalents and restricted cash
    		-3,861,000 13,083,000 -1,548,000 -14,510,000 1,730,000 -1,391,000 -1,713,000 3,722,000 -3,301,000 2,288,000 891,000 2,201,000 -5,299,000 -11,051,000 -996,000 3,047,000 3,588,000 -2,673,000  
      net increase in cash, cash equivalents and restricted cash
    		341,187,000 20,464,000 -1,198,000 352,535,000 89,223,000 -324,292,000 171,713,000 -40,514,000 228,548,000 -121,548,000 -483,301,000 -48,745,000 362,731,000 -1,124,758,000      
      cash, cash equivalents and restricted cash, beginning of period
    		1,756,423,000 0 0 0 1,295,399,000 0 0 0 1,259,944,000 0 0 0 1,550,807,000 0      
      cash, cash equivalents and restricted cash, end of period
    		2,097,610,000 20,464,000 -1,198,000 352,535,000 1,384,622,000 -324,292,000 171,713,000 -40,514,000 1,488,492,000 -121,548,000 -483,301,000 -48,745,000 1,913,538,000 -1,124,758,000      
      amortization of discount on securities available for sale
    		 -9,849,000 -7,564,000 -10,821,000 -15,797,000 9,481,000 -9,158,000 -11,002,000 -12,120,000 -12,349,000 -8,788,000 -7,303,000 -7,620,000 1,224,000      
      impairment of right of use assets
    		        752,000         403,000  
      acquisition, net of cash and restricted cash acquired
    		         0    0 0 0 -5,999,000   
      proceeds from the issuance of convertible notes
    		 0 0                 
      payments of tax withholding for stock-based compensation
    		 -62,225,000 -83,043,000 -95,335,000 -63,208,000 -40,983,000 -72,512,000 -39,159,000 -36,515,000 -10,356,000 -18,169,000 -18,009,000 -27,311,000 -18,236,000 -54,162,000 -72,963,000 -39,817,000 -30,714,000  
      repurchases of common stock
    		         0 0 0 -109,000 -2,000 -80,000 0 -4,000 -14,000 -3,000 
      other investing cash inflows/
    		     205,000 459,000 -34,725,000 56,000           
      repurchase of common stock
    		  0                 
      other investing cash inflows
    		   -814,000 15,197,000      1,787,000 1,640,000 -52,000 25,086,000 -20,647,000 5,045,000 4,827,000   
      proceeds from funding debt
    		    3,188,998,000 3,814,368,000 2,385,363,000 3,543,462,000 2,896,251,000 1,846,168,000 1,681,074,000 2,173,968,000 1,193,761,000 1,324,889,000 1,278,571,000 815,568,000 682,106,000 528,349,000 880,526,000 
      purchases of intangible assets
    		                   
      proceeds from issuance of convertible debt
    		             0 0     
      benefit from credit losses
    		      122,443,000 120,880,000 99,696,000 94,483,000 66,438,000 106,689,000 64,250,000 72,691,000 66,294,000 52,640,000 63,647,000 25,489,000 -17,346,000 
      purchases of loans held for sale
    		      -891,473,000 -1,022,671,000 -1,222,224,000 -1,289,572,000 -1,396,039,000 -1,668,537,000 -1,655,213,000 -1,683,335,000 -1,255,325,000 -1,717,216,000 -896,786,000 -1,000,062,000 -606,757,000 
      payable to third-party loan owners
    		      -4,837,000 25,069,000 55,646,000 9,665,000 -83,191,000 36,567,000 19,428,000 35,421,000 -35,553,000 33,054,000 -11,618,000 13,556,000 3,480,000 
      proceeds from issuance of notes and residual trust certificates by securitization trusts
    		      500,000,000 351,828,000 750,000,000 400,000,000 500,000,000 69,000 249,931,000 499,900,000 -146,000 -149,000 499,789,000  499,774,000 
      principal repayments of notes issued by securitization trusts
    		      0 -12,902,000 -515,377,000 -21,665,000 -25,251,000 -408,670,000 -150,713,000 -318,323,000 -131,256,000 -47,263,000 -55,204,000 -65,865,000 -74,113,000 
      proceeds from initial public offering
    		                 -125,000  
      proceeds from issuance of redeemable convertible preferred stock
    		                 0 0 
      repurchases and conversion of redeemable convertible preferred stock
    		                   
      other investing cash outflows
    		               -20,742,000 -3,000,000   
      repurchase and conversion of redeemable convertible preferred stock
    		                   
      acquisition of commercial agreement assets
    		                   
      conversion of redeemable convertible preferred stock
    		                   
      net increase in cash and cash equivalents and restricted cash
    		               1,138,990,000 -16,819,000 -114,370,000 1,170,212,000 
      cash and cash equivalents and restricted cash, beginning of period
    		               0 1,692,632,000 0 0 
      cash and cash equivalents and restricted cash, end of period
    		               1,138,990,000 1,675,813,000 -114,370,000 1,170,212,000 
      proceeds from exercise of common stock options and warrants
    		                37,470,000 3,227,000  
      (gain) loss on sales of loans
    		                   
      purchases and originations of loans held for investment
    		                   
      acquisitions, net of cash and restricted cash acquired
    		                   
      purchases of intangibles
    		                   
      proceeds from issuance of notes by securitization trusts
    		                   
      changes in fair value of servicing assets and liabilities
    		                  -2,545,000 
      changes in fair value and extinguishment of convertible debt derivative
    		                  0 
      change in fair value of residual trust certificates
    		                  -76,000 
      change in fair value of contingent consideration
    		                   
      income tax expense
    		                  -70,000 
      loss on disposal of property, equipment and software
    		                   
      purchases of loans held for investment
    		                  -1,425,140,000 
      origination of loans
    		                  -196,906,000 
      proceeds from the sale of loans
    		                  143,235,000 
      principal repayments of loans
    		                  1,301,542,000 
      repurchases of redeemable convertible preferred stock
    		                   
      supplemental disclosures of cash flow information
    		                   
      cash payments for interest
    		                  11,859,000 
      cash paid for income taxes
    		                   
      cash paid for operating leases
    		                   
      supplemental disclosures of non-cash investing and financing activities
    		                   
      stock-based compensation included in capitalized internal-use software
    		                  6,567,000 
      additions to property and equipment included in accrued expenses
    		                  0 
      issuance of warrants in exchange for commercial agreement
    		                  202,934,000 
      conversion of convertible debt
    		                  0 
      issuance of common stock in connection with acquisition
    		                   
      right of use assets obtained in exchange for operating lease liabilities
    		                   
      amortization of commercial agreement asset
    		                   
      acquisition funds in transit
    		                   
      proceeds from issuance of common stock
    		                   
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.